Having proved that DCLK1 promoted 5‐fluorouracil resistance through CCAR1/β‐catenin pathway‐mediated cancer stemness, we wondered whether targeting DCLK1 could suppress 5‐fluorouracil resistant CRC cells. The gene discussed is DCLK1; the disease is colorectal carcinoma.